Home/Filings/4/0001140361-12-051060
4//SEC Filing

Slager David Mark 4

Accession 0001140361-12-051060

CIK 0001176309other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 6:17 PM ET

Size

25.0 KB

Accession

0001140361-12-051060

Insider Transaction Report

Form 4
Period: 2012-11-29
Transactions
  • Expiration (Short)

    Warrants (Right to Purchase)

    2012-11-30202,7030 total(indirect: See)
    Exercise: $0.50From: 2012-11-05Exp: 2017-11-05Common Stock (202,703 underlying)
  • Expiration (Short)

    Warrants (Right to Purchase)

    2012-11-291,351,3520 total(indirect: See)
    Exercise: $0.50From: 2012-08-28Exp: 2017-08-28Common Stock (1,351,352 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-30+202,703202,703 total(indirect: See)
    Exercise: $0.31From: 2012-11-30Exp: 2017-11-05Common Stock (202,703 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-29+1,351,3521,351,352 total(indirect: See)
    Exercise: $0.31From: 2012-11-29Exp: 2017-08-28Common Stock (1,351,352 underlying)
  • Expiration (Short)

    Warrants (Right to Purchase)

    2012-11-293,485,5000 total(indirect: See)
    Exercise: $0.31From: 2012-01-10Exp: 2016-01-10Common Stock (3,485,500 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-29+3,485,5003,485,500 total(indirect: See)
    Exercise: $0.31From: 2012-11-29Exp: 2016-01-10Common Stock (3,485,500 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-29+1,647,7221,647,722 total(indirect: See)
    Exercise: $0.60From: 2012-11-29Exp: 2016-11-29Common Stock (1,647,722 underlying)
Transactions
  • Expiration (Short)

    Warrants (Right to Purchase)

    2012-11-30202,7030 total(indirect: See)
    Exercise: $0.50From: 2012-11-05Exp: 2017-11-05Common Stock (202,703 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-30+202,703202,703 total(indirect: See)
    Exercise: $0.31From: 2012-11-30Exp: 2017-11-05Common Stock (202,703 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-29+1,351,3521,351,352 total(indirect: See)
    Exercise: $0.31From: 2012-11-29Exp: 2017-08-28Common Stock (1,351,352 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-29+1,647,7221,647,722 total(indirect: See)
    Exercise: $0.60From: 2012-11-29Exp: 2016-11-29Common Stock (1,647,722 underlying)
  • Expiration (Short)

    Warrants (Right to Purchase)

    2012-11-291,351,3520 total(indirect: See)
    Exercise: $0.50From: 2012-08-28Exp: 2017-08-28Common Stock (1,351,352 underlying)
  • Expiration (Short)

    Warrants (Right to Purchase)

    2012-11-293,485,5000 total(indirect: See)
    Exercise: $0.31From: 2012-01-10Exp: 2016-01-10Common Stock (3,485,500 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-29+3,485,5003,485,500 total(indirect: See)
    Exercise: $0.31From: 2012-11-29Exp: 2016-01-10Common Stock (3,485,500 underlying)
Transactions
  • Purchase

    Warrants (Right to Purchase)

    2012-11-29+1,647,7221,647,722 total(indirect: See)
    Exercise: $0.60From: 2012-11-29Exp: 2016-11-29Common Stock (1,647,722 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-30+202,703202,703 total(indirect: See)
    Exercise: $0.31From: 2012-11-30Exp: 2017-11-05Common Stock (202,703 underlying)
  • Expiration (Short)

    Warrants (Right to Purchase)

    2012-11-30202,7030 total(indirect: See)
    Exercise: $0.50From: 2012-11-05Exp: 2017-11-05Common Stock (202,703 underlying)
  • Expiration (Short)

    Warrants (Right to Purchase)

    2012-11-291,351,3520 total(indirect: See)
    Exercise: $0.50From: 2012-08-28Exp: 2017-08-28Common Stock (1,351,352 underlying)
  • Expiration (Short)

    Warrants (Right to Purchase)

    2012-11-293,485,5000 total(indirect: See)
    Exercise: $0.31From: 2012-01-10Exp: 2016-01-10Common Stock (3,485,500 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-29+1,351,3521,351,352 total(indirect: See)
    Exercise: $0.31From: 2012-11-29Exp: 2017-08-28Common Stock (1,351,352 underlying)
  • Purchase

    Warrants (Right to Purchase)

    2012-11-29+3,485,5003,485,500 total(indirect: See)
    Exercise: $0.31From: 2012-11-29Exp: 2016-01-10Common Stock (3,485,500 underlying)
Footnotes (5)
  • [F1]On November 29, 2012, the Regals Fund LP, a Delaware limited partnership (the "Fund"), and the issuer amended the terms of the warrants previously issued by the issuer to the Fund by: (a) changing the exercise price of such warrants to $.3118, and/or (b) deleting any anti-dilution provisions with respect to new issuances from such warrants. In exchange for agreeing to amend the warrants, the Fund received an additional warrant exercisable for 1,647,722 shares of common stock and an option from an affiliate of the issuer to purchase up to 1,352,278 shares of common stock at a variable exercise price upon a trigger event.
  • [F2]The exercise price for such warrants reflects the exercise price after taking into account anti-dilution adjustments that occurred pursuant to the terms of such warrants (prior to the amendments described in note #1 above).
  • [F3]The number of shares underlying such warrants reflect the number of shares the warrants are exercisable for after taking into account anti-dilution adjustments that occurred pursuant to the terms of such warrants (prior to the amendments described in note #1 above).
  • [F4]Regals Capital Management LP, a Delaware limited partnership ("Regals Management"), the Fund, and David M. Slager ("Mr. Slager"), are the reporting persons (the "Reporting Persons") for the referenced securities. Mr. Slager is Managing Member of the general partner of Regals Management. Regals Management is the investment manager of the Fund. The shares of the issuer's common stock reported herein are held for the account of the Fund.
  • [F5]As a result, each of the Reporting Persons may be deemed to be a beneficial owner of the securities owned by the Fund for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended (the "Act"). Pursuant to Rule 16a-1(a)(4) under the Act, Regals Management and Mr. Slager disclaim beneficial ownership in the securities owned by the Fund except to the extent, if any, of their pecuniary interest therein.

Documents

1 file

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0001477733

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 6:17 PM ET
Size
25.0 KB